[1]
|
Pascual-Goñi, E., Martín-Aguilar, L. and Querol, L. (2019) Autoantibodies in Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Current Opinion in Neurology, 32, 651-657. https://doi.org/10.1097/wco.0000000000000725
|
[2]
|
Broers, M.C., Wieske, L., Erdag, E., Gürlek, C., Bunschoten, C., van Doorn, P.A., et al. (2023) Clinical Relevance of Distinguishing Autoimmune Nodopathies from CIDP: Longitudinal Assessment in a Large Cohort. Journal of Neurology, Neurosurgery & Psychiatry, 95, 52-60. https://doi.org/10.1136/jnnp-2023-331378
|
[3]
|
Van den Bergh, P.Y.K., van Doorn, P.A., Hadden, R.D.M., Avau, B., Vankrunkelsven, P., Allen, J.A., et al. (2021) European Academy of Neurology/Peripheral Nerve Society Guideline on Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Report of a Joint Task Force—Second Revision. European Journal of Neurology, 28, 3556-3583. https://doi.org/10.1111/ene.14959
|
[4]
|
Querol, L., Nogales-Gadea, G., Rojas-Garcia, R., Martinez-Hernandez, E., Diaz-Manera, J., Suárez-Calvet, X., et al. (2012) Antibodies to Contactin-1 in Chronic Inflammatory Demyelinating Polyneuropathy. Annals of Neurology, 73, 370-380. https://doi.org/10.1002/ana.23794
|
[5]
|
Ogata, H., Yamasaki, R., Hiwatashi, A., Oka, N., Kawamura, N., Matsuse, D., et al. (2015) Characterization of IgG4 Anti-Neurofascin 155 Antibody-Positive Polyneuropathy. Annals of Clinical and Translational Neurology, 2, 960-971. https://doi.org/10.1002/acn3.248
|
[6]
|
Pascual-Goñi, E., Fehmi, J., Lleixà, C., Martín-Aguilar, L., Devaux, J., Höftberger, R., et al. (2021) Antibodies to the Caspr1/Contactin-1 Complex in Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Brain, 144, 1183-1196. https://doi.org/10.1093/brain/awab014
|
[7]
|
Wang, L., Pan, J., Meng, H., Yang, Z., Zeng, L. and Liu, J. (2022) Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy. Brain Sciences, 12, Article 1587. https://doi.org/10.3390/brainsci12111587
|
[8]
|
Gao, Y., Kong, L., Liu, S., Liu, K. and Zhu, J. (2021) Impact of Neurofascin on Chronic Inflammatory Demyelinating Polyneuropathy via Changing the Node of Ranvier Function: A Review. Frontiers in Molecular Neuroscience, 14, Article 779385. https://doi.org/10.3389/fnmol.2021.779385
|
[9]
|
Rasband, M.N. and Peles, E. (2020) Mechanisms of Node of Ranvier Assembly. Nature Reviews Neuroscience, 22, 7-20. https://doi.org/10.1038/s41583-020-00406-8
|
[10]
|
Uncini, A. and Vallat, J. (2017) Autoimmune Nodo-Paranodopathies of Peripheral Nerve: The Concept Is Gaining Ground. Journal of Neurology, Neurosurgery & Psychiatry, 89, 627-635. https://doi.org/10.1136/jnnp-2017-317192
|
[11]
|
Uncini, A. and Kuwabara, S. (2015) Nodopathies of the Peripheral Nerve: An Emerging Concept. Journal of Neurology, Neurosurgery & Psychiatry, 86, 1186-1195. https://doi.org/10.1136/jnnp-2014-310097
|
[12]
|
Zhang, Y., Bekku, Y., Dzhashiashvili, Y., Armenti, S., Meng, X., Sasaki, Y., et al. (2012) Assembly and Maintenance of Nodes of Ranvier Rely on Distinct Sources of Proteins and Targeting Mechanisms. Neuron, 73, 92-107. https://doi.org/10.1016/j.neuron.2011.10.016
|
[13]
|
Manso, C., Querol, L., Lleixà, C., Poncelet, M., Mekaouche, M., Vallat, J., et al. (2019) Anti-Neurofascin-155 IgG4 Antibodies Prevent Paranodal Complex Formation in vivo. Journal of Clinical Investigation, 129, 2222-2236. https://doi.org/10.1172/jci124694
|
[14]
|
Manso, C., Querol, L., Mekaouche, M., Illa, I. and Devaux, J.J. (2016) Contactin-1 IgG4 Antibodies Cause Paranode Dismantling and Conduction Defects. Brain, 139, 1700-1712. https://doi.org/10.1093/brain/aww062
|
[15]
|
Cortese, A., Lombardi, R., Briani, C., Callegari, I., Benedetti, L., Manganelli, F., et al. (2020) Antibodies to Neurofascin, Contactin-1, and Contactin-Associated Protein 1 in CIDP. Neurology Neuroimmunology & Neuroinflammation, 7, e639. https://doi.org/10.1212/nxi.0000000000000639
|
[16]
|
Dalakas, M.C. (2022) IgG4-mediated Neurologic Autoimmunities. Neurology Neuroimmunology & Neuroinflammation, 9, e1116. https://doi.org/10.1212/nxi.0000000000001116
|
[17]
|
Doppler, K., Schuster, Y., Appeltshauser, L., Biko, L., Villmann, C., Weishaupt, A., et al. (2019) Anti-CNTN1 IgG3 Induces Acute Conduction Block and Motor Deficits in a Passive Transfer Rat Model. Journal of Neuroinflammation, 16, Article No. 73. https://doi.org/10.1186/s12974-019-1462-z
|
[18]
|
Koike, H., Kadoya, M., Kaida, K., Ikeda, S., Kawagashira, Y., Iijima, M., et al. (2017) Paranodal Dissection in Chronic Inflammatory Demyelinating Polyneuropathy with Anti-Neurofascin-155 and Anti-Contactin-1 Antibodies. Journal of Neurology, Neurosurgery & Psychiatry, 88, 465-473. https://doi.org/10.1136/jnnp-2016-314895
|
[19]
|
Martinez-Martinez, L., Lleixà, M.C., Boera-Carnicero, G., Cortese, A., Devaux, J., Siles, A., et al. (2017) Anti-NF155 Chronic Inflammatory Demyelinating Polyradiculoneuropathy Strongly Associates to HLA-DRB15. Journal of Neuroinflammation, 14, Article No. 224. https://doi.org/10.1186/s12974-017-0996-1
|
[20]
|
Vallat, J., Mathis, S., Magy, L., Bounolleau, P., Skarzynski, M., Heitzmann, A., et al. (2018) Subacute Nodopathy with Conduction Blocks and Anti-Neurofascin 140/186 Antibodies: An Ultrastructural Study. Brain, 141, e56. https://doi.org/10.1093/brain/awy134
|
[21]
|
Martín-Aguilar, L., Lleixà, C. and Pascual-Goñi, E. (2022) Autoimmune Nodopathies, an Emerging Diagnostic Category. Current Opinion in Neurology, 35, 579-585. https://doi.org/10.1097/wco.0000000000001107
|
[22]
|
Delmont, E., Manso, C., Querol, L., Cortese, A., Berardinelli, A., Lozza, A., et al. (2017) Autoantibodies to Nodal Isoforms of Neurofascin in Chronic Inflammatory Demyelinating Polyneuropathy. Brain, 140, 1851-1858. https://doi.org/10.1093/brain/awx124
|
[23]
|
Hu, W., Xin, Y., He, Z. and Zhao, Y. (2018) Association of Neurofascin IgG4 and Atypical Chronic Inflammatory Demyelinating Polyneuropathy: A Systematic Review and Meta-Analysis. Brain and Behavior, 8, e01115. https://doi.org/10.1002/brb3.1115
|
[24]
|
Painous, C., López-Pérez, M.Á., Illa, I. and Querol, L. (2018) Head and Voice Tremor Improving with Immunotherapy in an Anti-NF155 Positive CIDP Patient. Annals of Clinical and Translational Neurology, 5, 499-501. https://doi.org/10.1002/acn3.539
|
[25]
|
Briani, C., Salvalaggio, A., Ruiz, M., Cacciavillani, M., Rinaldi, F., Callegari, I., et al. (2019) Tongue Tremor in Neurofascin-155 IgG4 Seropositive Chronic Inflammatory Polyradiculoneuropathy. Journal of Neuroimmunology, 330, 178-180. https://doi.org/10.1016/j.jneuroim.2019.01.017
|
[26]
|
Vural, A., Doppler, K. and Meinl, E. (2018) Autoantibodies against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic Relevance. Frontiers in Immunology, 9, Article 1029. https://doi.org/10.3389/fimmu.2018.01029
|
[27]
|
Shelly, S., Klein, C.J., Dyck, P.J.B., Paul, P., Mauermann, M.L., Berini, S.E., et al. (2021) Neurofascin-155 Immunoglobulin Subtypes. Neurology, 97, e2392-e2403. https://doi.org/10.1212/wnl.0000000000012932
|
[28]
|
Devaux, J.J., Miura, Y., Fukami, Y., Inoue, T., Manso, C., Belghazi, M., et al. (2016) Neurofascin-155 IgG4 in Chronic Inflammatory Demyelinating Polyneuropathy. Neurology, 86, 800-807. https://doi.org/10.1212/wnl.0000000000002418
|
[29]
|
Hou, X., Liang, Y., Cui, P. and Hao, J. (2021) The Clinical Features of Combined Central and Peripheral Demyelination and Antibodies against the Node of Ranvier. Multiple Sclerosis Journal, 28, 453-462. https://doi.org/10.1177/13524585211028126
|
[30]
|
Kawamura, N., Yamasaki, R., Yonekawa, T., Matsushita, T., Kusunoki, S., Nagayama, S., et al. (2013) Anti-Neurofascin Antibody in Patients with Combined Central and Peripheral Demyelination. Neurology, 81, 714-722. https://doi.org/10.1212/wnl.0b013e3182a1aa9c
|
[31]
|
Klehmet, J., Staudt, M., Diederich, J., Siebert, E., Meinl, E., Harms, L., et al. (2017) Neurofascin (NF)155-and NF186-Specific T Cell Response in a Patient Developing a Central Pontocerebellar Demyelination after 10 Years of CIDP. Frontiers in Neurology, 8, Article 724. https://doi.org/10.3389/fneur.2017.00724
|
[32]
|
Wang, W., Liu, C., Li, W., Zhang, D., Shan, Y., Zheng, J., et al. (2022) Clinical and Diagnostic Features of Anti-Neurofascin-155 Antibody-Positive Neuropathy in Han Chinese. Annals of Clinical and Translational Neurology, 9, 695-706. https://doi.org/10.1002/acn3.51550
|
[33]
|
Ogata, H., Zhang, X., Inamizu, S., Yamashita, K., Yamasaki, R., Matsushita, T., et al. (2020) Optic, Trigeminal, and Facial Neuropathy Related to Anti-Neurofascin 155 Antibody. Annals of Clinical and Translational Neurology, 7, 2297-2309. https://doi.org/10.1002/acn3.51220
|
[34]
|
Kouton, L., Boucraut, J., Devaux, J., Rajabally, Y.A., Adams, D., Antoine, J.C., et al. (2020) Electrophysiological Features of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated with IgG4 Antibodies Targeting Neurofascin 155 or Contactin 1 Glycoproteins. Clinical Neurophysiology, 131, 921-927. https://doi.org/10.1016/j.clinph.2020.01.013
|
[35]
|
Miura, Y., Devaux, J.J., Fukami, Y., Manso, C., Belghazi, M., Wong, A.H.Y., et al. (2015) Contactin 1 IgG4 Associates to Chronic Inflammatory Demyelinating Polyneuropathy with Sensory Ataxia. Brain, 138, 1484-1491. https://doi.org/10.1093/brain/awv054
|
[36]
|
Delmont, E., Brodovitch, A., Kouton, L., Allou, T., Beltran, S., Brisset, M., et al. (2020) Antibodies against the Node of Ranvier: A Real-Life Evaluation of Incidence, Clinical Features and Response to Treatment Based on a Prospective Analysis of 1500 Sera. Journal of Neurology, 267, 3664-3672. https://doi.org/10.1007/s00415-020-10041-z
|
[37]
|
Appeltshauser, L., Weishaupt, A., Sommer, C. and Doppler, K. (2017) Complement Deposition Induced by Binding of Anti-Contactin-1 Auto-Antibodies Is Modified by Immunoglobulins. Experimental Neurology, 287, 84-90. https://doi.org/10.1016/j.expneurol.2016.10.006
|
[38]
|
Doppler, K., Appeltshauser, L., Wilhelmi, K., Villmann, C., Dib-Hajj, S.D., Waxman, S.G., et al. (2015) Destruction of Paranodal Architecture in Inflammatory Neuropathy with Anti-Contactin-1 Autoantibodies. Journal of Neurology, Neurosurgery & Psychiatry, 86, 720-728. https://doi.org/10.1136/jnnp-2014-309916
|
[39]
|
Tang, Y., Liu, J., Gao, F., Hao, H., Jia, Z., Zhang, W., et al. (2023) CIDP/Autoimmune Nodopathies with Nephropathy: A Case Series Study. Annals of Clinical and Translational Neurology, 10, 706-718. https://doi.org/10.1002/acn3.51754
|
[40]
|
Doppler, K., Appeltshauser, L., Villmann, C., Martin, C., Peles, E., Krämer, H.H., et al. (2016) Auto-Antibodies to Contactin-Associated Protein 1 (CASPR) in Two Patients with Painful Inflammatory Neuropathy. Brain, 139, 2617-2630. https://doi.org/10.1093/brain/aww189
|
[41]
|
Li, C., Zheng, H., Yuan, C., Li, Y., Hu, Y. and Jiang, H. (2022) Two CIDP Variants Patients with Anti-Caspr1 Antibodies in South China. Frontiers in Immunology, 13, Article 844036. https://doi.org/10.3389/fimmu.2022.844036
|
[42]
|
Liu, B., Zhou, L., Sun, C., Wang, L., Zheng, Y., Hu, B., et al. (2023) Clinical Profile of Autoimmune Nodopathy with Anti-Neurofascin 186 Antibody. Annals of Clinical and Translational Neurology, 10, 944-952. https://doi.org/10.1002/acn3.51775
|
[43]
|
Querol, L., Rojas-García, R., Diaz-Manera, J., Barcena, J., Pardo, J., Ortega-Moreno, A., et al. (2015) Rituximab in Treatment-Resistant CIDP with Antibodies against Paranodal Proteins. Neurology Neuroimmunology & Neuroinflammation, 2, e149. https://doi.org/10.1212/nxi.0000000000000149
|
[44]
|
Martín-Aguilar, L., Lleixà, C., Pascual-Goñi, E., et al. (2022) Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy. Neurology Neuroimmunology & Neuroinflammation, 9, e1129. https://doi.org/10.1212/NXI.0000000000001129
|
[45]
|
Bresciani, L., Salvalaggio, A., Vegezzi, E., Visentin, A., Fortuna, A., Anglani, M., et al. (2023) Caspr1 Antibodies Autoimmune Paranodopathy with Severe Tetraparesis: Potential Relevance of Antibody Titers in Monitoring Treatment Response. Journal of the Peripheral Nervous System, 28, 522-527. https://doi.org/10.1111/jns.12565
|
[46]
|
Mehndiratta, M.M., Hughes, R.A. and Pritchard, J. (2015) Plasma Exchange for Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Cochrane Database of Systematic Reviews, No. 8, Article No. CD003906. https://doi.org/10.1002/14651858.cd003906.pub4
|
[47]
|
Bunschoten, C., Jacobs, B.C., Van den Bergh, P.Y.K., Cornblath, D.R. and van Doorn, P.A. (2019) Progress in Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. The Lancet Neurology, 18, 784-794. https://doi.org/10.1016/s1474-4422(19)30144-9
|
[48]
|
Yang, M., Xu, L., Ji, S., Gao, H., Zhang, Q. and Bu, B. (2022) Tacrolimus Combined with Corticosteroids Improved the Outcome of CIDP Patients with Autoantibodies against Paranodal Proteins. Neuropsychiatric Disease and Treatment, 18, 1207-1217. https://doi.org/10.2147/ndt.s361461
|